IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity.
D'Auria
L
L
Laboratory of Clinical Pathology, Institute S. Gallicano, Rome, Italy.
Pietravalle
M
M
Mastroianni
A
A
Ferraro
C
C
Mussi
A
A
Bonifati
C
C
Giacalone
B
B
Ameglio
F
F
D000368:Aged; D000369:Aged, 80 and over; D001768:Blister / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism; D001826:Body Fluids / Q000378:metabolism*; D016022:Case-Control Studies; D018946:Chemokine CCL5 / Q000378:metabolism; D047091:Eosinophil Granule Proteins; D004804:Eosinophils / Q000378:metabolism; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism*; D018836:Inflammation Mediators / Q000378:metabolism; D015848:Interleukin-5 / Q000097:blood / Q000378:metabolism*; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism*; D012260:Ribonucleases
D001798:Blood Proteins; D018946:Chemokine CCL5; D047091:Eosinophil Granule Proteins; D018836:Inflammation Mediators; D015848:Interleukin-5; D011506:Proteins; D007073:Immunoglobulin E; D012260:Ribonucleases